Capsugel – Now a Lonza Company
Articles
Enabling Formulations of Poorly Absorbable Drugs with Capsule Solutions
May 18th 2021Two Airings! * NA, EMEA, LATAM: Tuesday, May 18, 2021 at 11am EDT |8am PDT| 4pm BST| 5pm CEST and APAC: Tuesday, May 25, 2021 at 4pm JST| 3pm CST| 5pm AEST| 12:30pm IST* Learn more about possible solutions to help overcome the challenges of formulating poorly absorbable APIs with different oral dosage forms. *On Demand Until May 25, 2022*
Capsugel® Dry-Powder Inhalation Capsule Portfolio
May 21st 2019Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI device is a simple and cost-effective way to deliver inhalable medication.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: October 28th 2024 | Updated: November 23rd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 6th 2024 | Updated: November 23rd 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 23rd 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 23rd 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
